|
Vanta Bioscience Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
13.31 Cr.
|
P/BV
|
0.69
|
Book Value (Rs.)
|
27.06
|
|
52 Week High/Low (Rs.)
|
44/18
|
FV/ML
|
10/750
|
P/E(X)
|
0.00
|
|
Bookclosure
|
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | -7.56 | -3.67 | -10.27 | 0.14 | 0.07 |
| Diluted EPS (Rs.) | -7.56 | -3.67 | -10.27 | 0.14 | 0.07 |
| Cash EPS (Rs.) | -14.06 | -6.51 | -12.32 | 2.30 | 2.69 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 16.51 | 24.08 | 29.99 | 46.49 | 41.55 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 16.51 | 24.08 | 29.99 | 46.49 | 41.55 |
| Revenue From Operations / Share (Rs.) | 3.11 | 15.40 | 9.94 | 15.35 | 15.90 |
| PBDIT / Share (Rs.) | -6.57 | 2.25 | -2.70 | 6.17 | 6.30 |
| PBIT / Share (Rs.) | -13.56 | -4.88 | -6.93 | 4.08 | 4.32 |
| PBT / Share (Rs.) | -20.01 | -13.98 | -16.26 | 0.36 | 0.93 |
| Net Profit / Share (Rs.) | -21.06 | -13.63 | -16.55 | 0.21 | 0.71 |
| NP After MI And SOA / Share (Rs.) | -7.56 | -3.67 | -10.27 | 0.13 | 0.71 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | -211.13 | 14.59 | -27.19 | 40.16 | 39.65 |
| PBIT Margin (%) | -436.01 | -31.65 | -69.74 | 26.58 | 27.18 |
| PBT Margin (%) | -643.16 | -90.78 | -163.52 | 2.35 | 5.86 |
| Net Profit Margin (%) | -676.83 | -88.51 | -166.42 | 1.39 | 4.46 |
| NP After MI And SOA Margin (%) | -243.17 | -23.81 | -103.26 | 0.91 | 4.47 |
| Return on Networth / Equity (%) | -45.80 | -15.23 | -37.00 | 0.36 | 1.87 |
| Return on Capital Employeed (%) | -14.43 | -4.92 | -6.53 | 3.83 | 4.98 |
| Return On Assets (%) | -5.55 | -2.71 | -7.65 | 0.10 | 0.64 |
| Long Term Debt / Equity (X) | 5.19 | 3.21 | 2.69 | 1.54 | 1.16 |
| Total Debt / Equity (X) | 6.72 | 4.01 | 3.26 | 1.87 | 1.34 |
| Asset Turnover Ratio (%) | 0.02 | 0.11 | 0.07 | 0.12 | 0.21 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 0.57 | 0.75 | 0.85 | 1.02 | 1.34 |
| Quick Ratio (X) | 0.33 | 0.42 | 0.45 | 0.50 | 0.68 |
| Inventory Turnover Ratio (X) | 0.27 | 0.15 | 0.11 | 0.08 | 0.06 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | -1.02 | 0.24 | -0.28 | 1.66 | 1.86 |
| Interest Coverage Ratio (Post Tax) (%) | -2.27 | -0.49 | -0.77 | 1.06 | 1.21 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 77.18 | 98.96 | 94.77 | 119.32 | 134.53 |
| EV / Net Operating Revenue (X) | 39.31 | 10.18 | 15.10 | 12.32 | 13.40 |
| EV / EBITDA (X) | -18.62 | 69.73 | -55.53 | 30.66 | 33.80 |
| MarketCap / Net Operating Revenue (X) | 7.11 | 4.15 | 5.78 | 7.16 | 10.25 |
| Price / BV (X) | 1.34 | 2.66 | 2.07 | 2.89 | 4.30 |
| Price / Net Operating Revenue (X) | 7.11 | 4.16 | 5.78 | 7.16 | 10.25 |
| EarningsYield | -0.34 | -0.05 | -0.17 | 0.00 | 0.00 |
